Dimensional connectomics of anxious misery
焦虑痛苦的维度连接组学
基本信息
- 批准号:9285832
- 负责人:
- 金额:$ 69.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-03 至 2020-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAgeAlgorithmsAmbulatory Care FacilitiesAmericanAnatomyBehaviorBehavioralBrainBrain imagingChronicClinicalClinical assessmentsCognitiveDNADataData SetDatabasesDimensionsDiseaseDisease MarkerFunctional disorderGeneralized Anxiety DisorderGeneticGoalsGraphHealthHumanImageIndividualLengthMajor Depressive DisorderMeasuresModalityNational Institute of Mental HealthNegative ValenceNeurocognitiveParticipantPatient Self-ReportPatientsPatternPennsylvaniaPopulationPost-Traumatic Stress DisordersProceduresProtocols documentationPsychiatric DiagnosisRecruitment ActivityResearchResearch Domain CriteriaResearch PersonnelRiskSamplingScienceSeveritiesSymptomsSystemTestingTrainingTreatment EfficacyUnited States National Institutes of HealthUniversitiesValidationanxiousbasebrain behaviorbrain circuitrycomputerizedconnectomedata sharingdisabling symptomexhaustfollow-upinnovationneuroimagingnovelphenomenological modelspredict clinical outcomeprismapublic health relevanceresponsetool
项目摘要
DESCRIPTION (provided by applicant): Every year more than 30% (2 billion) of the world's population and 75 million adult Americans suffer from disorders that have been lumped under the term "anxious misery." Among patients who receive treatment, a large number remain with debilitating symptoms, often for years or decades. Recently the NIMH has led efforts to define constructs within the Negative Valence System (NVS) that cut across such disorders in order to spur research on underlying mechanisms. This application will focus on potential brain circuitry and behaviors associated with "loss", and "responses to sustained threat," two of the most central NVS dimensions. By considering these brain circuits jointly, we can disentangle these dimensions for more specific targeting of disabling symptoms. Recent improvements in treatment efficacy have been shown in studies that target regions by mapping individual anatomy and connectivity patterns. This application, submitted in response to PAR-14-281, by a team of investigators at the forefront of understanding NVS disorders, will comprehensively characterize NVS spectrum disorders using the RDoC framework, focusing on brain circuits important in pathophysiology across the spectrum of loss and responses to sustained threat. By implementing neuroimaging assessment on a single Prisma scanner optimized for compatibility with the Human Connectome Protocol (HCP) and by collecting demographic data, neurocognitive data using the NIH Toolbox and Penn Computerized Neurocognitive Battery (CNB), and DNA samples, along with specialized assessments pertinent to NVS disorders, we will expand the HCP database with a highly significant pathophysiology sample for human health. These goals will be achieved by recruiting 50 control participants and 200 participants with anxious misery symptoms from the Outpatient Clinics of the University of Pennsylvania, where they will undergo an extensive multi-modal assessment to characterize the cross-sectional phenomenology of these NVS domains and a one-year followup to assess subsequent symptoms. The proposed project has both objectives and hypotheses. The main objective is to acquire and make public a vast database of brain imaging and behavioral data from patients with anxious misery as well as innovative new tools to analyze brain connectome changes. This objective includes careful QA and harmonization procedures. The main hypothesis to be tested is that severity of responses to sustained threat and loss correlate with dissociable circuit abnormalities in the structural and functional connectome; further, these abnormalities will predict course of illness.
描述(由适用提供):每年有超过30%(20亿)人口和7500万成年美国人患有“焦虑痛苦”一词的疾病。在接受治疗的患者中,大量症状仍然令人衰弱,通常数年或几十年。最近,NIMH领导了努力定义负面价系统(NVS)中的结构,这些构建体涉及这些疾病,以刺激基础机制的研究。该应用将集中于潜在的脑电路和与“损失”和“对持续威胁的反应”相关的行为,这是两个最中心的NVS维度。通过共同考虑这些大脑电路,我们可以解散这些维度,以更具体地靶向禁用症状。通过绘制单个解剖结构和连通性模式来靶向区域的研究表明,治疗效率的最新提高。该应用程序是由一组理解NVS疾病的研究人员团队提交的,该应用程序将使用RDOC框架全面地表征NVS光谱障碍,重点是脑电路对跨损失光谱和持续威胁的病理生理学重要。通过对单个Prisma扫描仪进行神经影像的评估,该评估优化了与人类Connectome协议(HCP)的兼容性,并通过NIH工具箱和Penn计算机化的神经认知电池(CNB)(CNB)(CNB)以及DNA样本以及对NVS的专门评估,我们将使用NIH计算机化的神经认知电池(CNB)收集人口统计学数据,神经认知数据,我们将扩展HCP,我们将扩展HCP,我们将扩展hcpsips anc。 健康。这些目标将通过招募50名对照参与者和200名参与者从宾夕法尼亚大学门诊诊所出现焦虑症状症状,在那里他们将接受广泛的多模式评估,以表征这些NVS领域的横断面现象学,并进行一年的随访,以评估后续症状。拟议的项目既有目标又有假设。主要目的是从焦虑痛苦的患者以及创新的新工具中获取并使公众成为大脑成像和行为数据的庞大数据库,以分析脑连接的变化。该目标包括仔细的质量检查和协调程序。要测试的主要假设是,对持续威胁和损失的响应严重程度与结构和功能连接中的可分离电路异常相关。此外,这些异常将预测疾病的病程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YVETTE I SHELINE其他文献
YVETTE I SHELINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YVETTE I SHELINE', 18)}}的其他基金
3/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
3/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10670909 - 财政年份:2022
- 资助金额:
$ 69.41万 - 项目类别:
Reducing neural perseveration through closed loop real time fMRI neurofeedback to alleviate depressive symptoms
通过闭环实时功能磁共振成像神经反馈减少神经持久性,以缓解抑郁症状
- 批准号:
10539326 - 财政年份:2021
- 资助金额:
$ 69.41万 - 项目类别:
Reducing neural perseveration through closed loop real time fMRI neurofeedback to alleviate depressive symptoms
通过闭环实时功能磁共振成像神经反馈减少神经持久性,以缓解抑郁症状
- 批准号:
10356604 - 财政年份:2021
- 资助金额:
$ 69.41万 - 项目类别:
Novel neural circuit biomarkers of depression response to computer-augmented CBT
计算机增强 CBT 抑郁反应的新型神经回路生物标志物
- 批准号:
9908160 - 财政年份:2017
- 资助金额:
$ 69.41万 - 项目类别:
Novel neural circuit biomarkers of depression response to computer-augmented CBT
计算机增强 CBT 抑郁反应的新型神经回路生物标志物
- 批准号:
10166929 - 财政年份:2017
- 资助金额:
$ 69.41万 - 项目类别:
Integrative Training in the Neurocircuitry of Affective Disorders
情感障碍神经回路的综合训练
- 批准号:
9917853 - 财政年份:2016
- 资助金额:
$ 69.41万 - 项目类别:
Citalopram Decreases CSF AB: A Randomized Dose Finding Trial
西酞普兰减少 CSF AB:随机剂量探索试验
- 批准号:
8811213 - 财政年份:2014
- 资助金额:
$ 69.41万 - 项目类别:
Citalopram Decreases CSF AB: A Randomized Dose Finding Trial
西酞普兰减少 CSF AB:随机剂量探索试验
- 批准号:
8893854 - 财政年份:2014
- 资助金额:
$ 69.41万 - 项目类别:
Citalopram Decreases CSF AB: A Randomized Dose Finding Trial
西酞普兰减少 CSF AB:随机剂量探索试验
- 批准号:
8701208 - 财政年份:2014
- 资助金额:
$ 69.41万 - 项目类别:
STRESS AND INFLAMMATION IN THE PATHOPHYSIOLOGY OF LATE-LIFE DEPRESSION
晚年抑郁症病理生理学中的压力和炎症
- 批准号:
8499914 - 财政年份:2013
- 资助金额:
$ 69.41万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 69.41万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 69.41万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 69.41万 - 项目类别:
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:
10551184 - 财政年份:2023
- 资助金额:
$ 69.41万 - 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 69.41万 - 项目类别: